NYSE:NSRX | Free Cash Flow | Nasus Pharma Ltd

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2023-12-31 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$4.92M$14,000.00-$4.93M
2024-12-31-$665,000.00
2023-12-31-$1.03M